Corrigendum to “A multi-step, allosteric model of testosterone's binding to sex hormone binding globulin” [Molecular and Cellular Endocrinology 399 (2015) 190–200](S030372071400272X)(10.1016/j.mce.2014.09.001);A multi-step, dynamic allosteric model of testosterone's binding to sex hormone binding globulin

Molecular and Cellular Endocrinology

Volumn 399, Issue , 2015, Pages 190-200

  Zakharov, Mikhail N ^a   Bhasin, Shalender ^a   Travison, Thomas G ^a   Xue, Ran ^a   Ulloor, Jagadish ^a   Vasan, Ramachandran S ^b   Carter, Emma ^c   Wu, Frederick ^c   Jasuja, Ravi ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Allostery; Free testosterone; SHBG; Steroid transport; Testosterone

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; GLOBULIN; TESTOSTERONE; SEX HORMONE BINDING GLOBULIN;

ADULT; AGED; ALLOSTERISM; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOTIC LIGAND MODEL; CONTROLLED STUDY; EQUILIBRIUM DIALYSIS; FEMALE; HORMONE PROTEIN COMPLEX; HORMONE TRANSPORT; HUMAN; ISOTHERMAL TITRATION CALORIMETRY; LIGAND BINDING; MALE; MIDDLE AGED; NORMAL HUMAN; PROTEIN BINDING; REACTION ANALYSIS; STEROID BINDING; TESTOSTERONE BLOOD LEVEL; THERMODYNAMICS; VERY ELDERLY; CHEMICAL MODEL; CHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION;

ALLOSTERIC REGULATION; FEMALE; HUMANS; MALE; MODELS, CHEMICAL; PROTEIN MULTIMERIZATION; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84908568336     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2017.07.032     Document Type: Erratum

References (50)

1. Adachi K., Yasuda K., Fuwa Y., Goshima E., Yamakita N., Miura K. Measurement of plasma free steroids by direct radioimmunoassay of ultrafiltrate in association with the monitoring of free components with [14C]glucose. Clin. Chim. Acta 1991, 200:13-22.
2. Avvakumov G.V., Muller Y.A., Hammond G.L. Steroid-binding specificity of human sex hormone-binding globulin is influenced by occupancy of a zinc-binding site. J. Biol. Chem 2000, 275:25920-25925.
3. Avvakumov G.V., Grishkovskaya I., Muller Y.A., Hammond G.L. Resolution of the human sex hormone-binding globulin dimer interface and evidence for two steroid-binding sites per homodimer. J. Biol. Chem 2001, 276:34453-34457.
4. Avvakumov G.V., Grishkovskaya I., Muller Y.A., Hammond G.L. Crystal structure of human sex hormone-binding globulin in complex with 2-methoxyestradiol reveals the molecular basis for high affinity interactions with C-2 derivatives of estradiol. J. Biol. Chem 2002, 277:45219-45225.
5. Avvakumov G.V., Cherkasov A., Muller Y.A., Hammond G.L. Structural analyses of sex hormone-binding globulin reveal novel ligands and function. Mol. Cell. Endocrinol 2010, 316:13-23.
6. Bhasin S., Cunningham G.R., Hayes F.J., Matsumoto A.M., Snyder P.J., Swerdloff R.S., et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab 2010, 95:2536-2559.
7. Bhasin S., Pencina M., Jasuja G.K., Travison T.G., Coviello A., Orwoll E., et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the framingham heart study and applied to three geographically distinct cohorts. J. Clin. Endocrinol. Metab 2011, 96:2430-2439.
8. Bhasin S., Travison T.G., Storer T.W., Lakshman K., Kaushik M., Mazer N.A., et al. Effect of testosterone supplementation with and without a dual 5alpha-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial. JAMA 2012, 307:931-939.
9. Dunn J.F., Nisula B.C., Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J. Clin. Endocrinol. Metab 1981, 53:58-68.
10. Elveback L. The population of healthy persons as a source of reference information. Hum. Pathol 1973, 4:9-16.
11. Freiburger L.A., Baettig O.M., Sprules T., Berghuis A.M., Auclair K., Mittermaier A.K. Competing allosteric mechanisms modulate substrate binding in a dimeric enzyme. Nat. Struct. Mol. Biol 2011, 18:288-294.
12. Grishkovskaya I., Sklenar G., Avvakumov G.V., Dales D., Behlke J., Hammond G.L., et al. Crystallization of the N-terminal domain of human sex hormone-binding globulin, the major sex steroid carrier in blood. Acta Crystallogr. D Biol. Crystallogr 1999, 55:2053-2055.
13. Grishkovskaya I., Avvakumov G.V., Sklenar G., Dales D., Hammond G.L., Muller Y.A. Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain. EMBO J. 2000, 19:504-512.
14. Grishkovskaya I., Avvakumov G.V., Hammond G.L., Catalano M.G., Muller Y.A. Steroid ligands bind human sex hormone-binding globulin in specific orientations and produce distinct changes in protein conformation. J. Biol. Chem 2002, 277:32086-32093.
15. Hammond G.L., Bocchinfuso W.P. Sex hormone-binding globulin: gene organization and structure/function analyses. Horm. Res 1996, 45:197-201.
16. Hauptmann H., Metzger J., Schnitzbauer A., Cuilleron C.Y., Mappus E., Luppa P.B. Syntheses and ligand-binding studies of 1 alpha- and 17 alpha-aminoalkyl dihydrotestosterone derivatives to human sex hormone-binding globulin. Steroids 2003, 68:629-639.
17. Hilser V.J., Thompson E.B. Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins. Proc. Natl Acad. Sci. U.S.A. 2007, 104:8311-8315.
18. Huang G., Basaria S., Travison T.G., Ho M.H., Davda M., Mazer N.A., et al. Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial. Menopause 2014, 21:612-623.
19. Koshland D.E., Nemethy G., Filmer D. Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry 1966, 5:365-385.
20. Krasnoff J.B., Basaria S., Pencina M.J., Jasuja G.K., Vasan R.S., Ulloor J., et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J. Clin. Endocrinol. Metab 2010, 95:2790-2799.
21. Lee D.M., O'Neill T.W., Pye S.R., Silman A.J., Finn J.D., Pendleton N., et al. The European Male Ageing Study (EMAS): design, methods and recruitment. Int. J. Androl 2009, 32:11-24.
22. Ly L.P., Handelsman D.J. Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur. J. Endocrinol 2005, 152:471-478.
23. Ly L.P., Sartorius G., Hull L., Leung A., Swerdloff R.S., Wang C., et al. Accuracy of calculated free testosterone formulae in men. Clin. Endocrinol. (Oxf) 2010, 73:382-388.
24. Mazer N.A. A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations. Steroids 2009, 74:512-519.
25. Mendel C.M. The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev 1989, 10:232-274.
26. Metzger J., Schnitzbauer A., Meyer M., Soder M., Cuilleron C.Y., Hauptmann H., et al. Binding analysis of 1alpha- and 17alpha-dihydrotestosterone derivatives to homodimeric sex hormone-binding globulin. Biochemistry 2003, 42:13735-13745.
27. Monod J., Wyman J., Changeux J.P. On the nature of allosteric transitions: a plausible model. J. Mol. Biol 1965, 12:88-118.
28. Morales A., Collier C.P., Clark A.F. A critical appraisal of accuracy and cost of laboratory methodologies for the diagnosis of hypogonadism: the role of free testosterone assays. Can. J. Urol 2012, 19:6314-6318.
29. Morley J.E., Patrick P., Perry H.M. Evaluation of assays available to measure free testosterone. Metabolism 2002, 51:554-559.
30. Nanjee M.N., Wheeler M.J. Plasma free testosterone - is an index sufficient?. Ann. Clin. Biochem 1985, 22(Pt 4):387-390.
31. Ohlsson C., Wallaschofski H., Lunetta K.L., Stolk L., Perry J.R., Koster A., et al. Genetic determinants of serum testosterone concentrations in men. PLoS Genet 2011, 7:e1002313.
32. Petra P.H., Namkung P.C., Senear D.F., McCrae D.A., Rousslang K.W., Teller D.C., et al. Molecular characterization of the sex steroid binding protein (SBP) of plasma. Re-examination of rabbit SBP and comparison with the human, macaque and baboon proteins. J. Steroid Biochem 1986, 25:191-200.
33. Rosner W. Plasma steroid-binding proteins. Endocrinol. Metab. Clin. North Am 1991, 20:697-720.
34. Rosner W. Errors in the measurement of plasma free testosterone. J. Clin. Endocrinol. Metab 1997, 82:2014-2015.
35. Rosner W., Auchus R.J., Azziz R., Sluss P.M., Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J. Clin. Endocrinol. Metab 2007, 92:405-413.
36. Sartorius G., Ly L.P., Sikaris K., McLachlan R., Handelsman D.J. Predictive accuracy and sources of variability in calculated free testosterone estimates. Ann. Clin. Biochem 2009, 46:137-143.
37. Sinha-Hikim I., Arver S., Beall G., Shen R., Guerrero M., Sattler F., et al. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J. Clin. Endocrinol. Metab 1998, 83:1312-1318.
38. Sodergard R., Backstrom T., Shanbhag V., Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J. Steroid Biochem 1982, 16:801-810.
39. Solberg H.E. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values, and International Committee for Standardization in Haematology (ICSH), Standing Committee on Reference Values. Approved Recommendation (1986) on the theory of reference values. Part 1. The concept of reference values. J. Clin. Chem. Clin. Biochem 1987, 25:337-342.
40. Spitzer M., Basaria S., Travison T.G., Davda M.N., Paley A., Cohen B., et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann. Intern. Med 2012, 157:681-691.
41. Splansky G.L., Corey D., Yang Q., Atwood L.D., Cupples L.A., Benjamin E.J., et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am. J. Epidemiol 2007, 165:1328-1335.
42. Tajar A., Forti G., O'Neill T.W., Lee D.M., Silman A.J., Finn J.D., et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J. Clin. Endocrinol. Metab 2010, 95:1810-1818.
43. Van Uytfanghe K., Stockl D., Kaufman J.M., Fiers T., Ross H.A., De Leenheer A.P., et al. Evaluation of a candidate reference measurement procedure for serum free testosterone based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry. Clin. Chem 2004, 50:2101-2110.
44. Velazquez-Campoy A., Ohtaka H., Nezami A., Muzammil S., Freire E. Isothermal titration calorimetry 2004, Curr. Protoc. Cell. Biol., Chapter 17) Unit 17.8.
45. Vermeulen A., Stoica T., Verdonck L. The apparent free testosterone concentration, an index of androgenicity. J. Clin. Endocrinol. Metab 1971, 33:759-767.
46. Vermeulen A., Verdonck L., Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab 1999, 84:3666-3672.
47. Winters S.J., Kelley D.E., Goodpaster B. The analog free testosterone assay: are the results in men clinically useful?. Clin. Chem 1998, 44:2178-2182.
48. Wood S.N. Generalized Additive Models: An Introduction with R 2006,391. Chapman & Hall/CRC, Boca Raton, FL.
49. Wu F.C., Tajar A., Beynon J.M., Pye S.R., Silman A.J., Finn J.D., et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N. Engl. J. Med 2010, 363:123-135.
50. Zakharov M.N., Bhasin S., Szafran A.T., Mancini M.A., Jasuja R. Numerical framework to model temporally resolved multi-stage dynamic systems. Comput. Methods Programs Biomed 2012, 108:750-759.